3B Blackbio DX Ltd Gains 13.07%: 2 Key Technical Signals Driving the Rally

2 hours ago
share
Share Via
3B Blackbio DX Ltd delivered a robust weekly gain of 13.07%, closing at Rs.1,654.80 on 1 Oct 2026, significantly outperforming the Sensex which declined 3.20% over the same period. The stock’s strong performance was driven by a shift to a mildly bullish technical momentum and the formation of a Golden Cross, signalling potential for sustained upward movement amid a challenging broader market environment.

Key Events This Week

Sep 28: New 52-week high (Rs.1,580.90)

Sep 29: Continued gains with Rs.1,625.10 close (+2.80%)

Sep 30: Further rally to Rs.1,693.15 (+4.19%)

Oct 01: Golden Cross formation, slight pullback to Rs.1,654.80 (-2.27%)

Week Open
Rs.1,463.50
Week Close
Rs.1,654.80
+13.07%
Week High
Rs.1,693.15
vs Sensex
+16.27%

Monday, 28 September 2026: Technical Momentum Shift Sparks Rally

3B Blackbio DX Ltd began the week with a strong technical momentum shift, moving from a sideways trend to a mildly bullish stance. The stock surged 8.02% to close at Rs.1,580.90, marking a new 52-week high. This move contrasted sharply with the Sensex, which fell 1.60% to 34,788.97, highlighting the stock’s relative strength amid a broader market decline.

The shift was supported by positive technical indicators including a bullish weekly MACD and expanding Bollinger Bands, signalling increased volatility in favour of higher prices. Despite daily moving averages remaining mildly bearish, the stock’s price action suggested growing investor interest within the healthcare services sector. The MarketsMOJO score of 57.0 and an upgraded Hold rating further reinforced the improving outlook.

Tuesday, 29 September 2026: Continued Uptrend with Moderate Volume

The stock maintained its upward trajectory, gaining 2.80% to close at Rs.1,625.10. This steady advance occurred on lower volume compared to Monday, indicating a measured but sustained buying interest. The Sensex again declined, albeit modestly by 0.48%, closing at 34,621.52, underscoring the stock’s outperformance.

Technical oscillators remained supportive, with the weekly MACD bullish and the RSI neutral, suggesting room for further appreciation without immediate overbought risk. The stock’s position near the upper end of its 52-week range continued to attract attention as a potential growth candidate within its micro-cap healthcare segment.

Our current Stock of the Month is out! This Large Cap from Automobiles - Passenger Cars emerged as the single best opportunity from our elite universe. Get the details now!

  • - Current monthly selection
  • - Single best opportunity
  • - Elite universe pick

Get the Full Details →

Wednesday, 30 September 2026: Rally Accelerates to Weekly High

The stock accelerated its gains, climbing 4.19% to reach Rs.1,693.15, the highest close of the week. This marked a cumulative gain of over 15% from the previous Friday’s close of Rs.1,463.50. The Sensex continued its downward trend, slipping 0.17% to 34,564.37, further emphasising the stock’s strong relative performance.

Technical indicators aligned to support this rally, with the weekly MACD bullish and Bollinger Bands expanding, signalling increased upward momentum. The monthly MACD remained mildly bearish, suggesting that while short-term momentum was strong, longer-term confirmation was still pending. Investors were advised to monitor moving average crossovers for signs of sustained trend reversal.

Thursday, 1 October 2026: Golden Cross Formation Signals Potential Breakout

Despite a slight pullback of 2.27% to Rs.1,654.80, 3B Blackbio DX Ltd formed a significant technical pattern known as the Golden Cross, where the 50-day moving average crossed above the 200-day moving average. This event is widely regarded as a bullish signal indicating a potential long-term trend reversal and breakout.

The Golden Cross was supported by bullish MACD readings on both weekly and monthly charts, and Bollinger Bands showing expanding volatility in favour of higher prices. The Relative Strength Index remained neutral, suggesting the stock was not overextended. The slight dip on the day of the crossover may represent a consolidation phase before further gains.

Fundamentally, the stock’s price-to-earnings ratio stood at 25.66, slightly above the healthcare sector average of 24.47, reflecting moderate valuation. The company’s micro-cap status and market capitalisation of ₹1,454 crores imply higher volatility but also growth potential within the healthcare services sector.

Is 3B Blackbio DX Ltd your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!

  • - Better alternatives suggested
  • - Cross-sector comparison
  • - Portfolio optimization tool

Find Better Alternatives →

Daily Price Comparison: 3B Blackbio DX Ltd vs Sensex

Date Stock Price Day Change Sensex Day Change
2026-09-28 Rs.1,580.90 +8.02% 34,788.97 -1.60%
2026-09-29 Rs.1,625.10 +2.80% 34,621.52 -0.48%
2026-09-30 Rs.1,693.15 +4.19% 34,564.37 -0.17%
2026-10-01 Rs.1,654.80 -2.27% 34,221.41 -0.99%

Key Takeaways

Positive Signals: The stock’s 13.07% weekly gain amid a 3.20% Sensex decline highlights strong relative strength. The formation of the Golden Cross on 1 Oct 2026 is a pivotal technical event signalling a potential long-term bullish breakout. Weekly MACD and Bollinger Bands support upward momentum, while the MarketsMOJO Hold rating and improved mojo score reflect enhanced market sentiment.

Cautionary Notes: The monthly MACD remains mildly bearish, suggesting longer-term momentum confirmation is pending. The slight pullback on the day of the Golden Cross formation may indicate short-term consolidation. The stock’s micro-cap status and valuation slightly above sector average imply higher volatility and moderate risk.

Conclusion

3B Blackbio DX Ltd demonstrated a compelling technical and price performance during the week ending 1 October 2026, driven by a shift to bullish momentum and the significant Golden Cross formation. The stock’s ability to outperform the Sensex by over 16 percentage points amid a declining market underscores its resilience and potential within the healthcare services sector. While short-term fluctuations and mixed longer-term signals counsel caution, the overall technical landscape suggests that 3B Blackbio DX Ltd is entering a phase of renewed strength. Investors should monitor key technical levels and broader market conditions to assess the sustainability of this positive trend.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News